JPRN-UMIN000016756
Completed
未知
Multi-institutional cohort study of evaluating safety and efficacy of surgical treatment for elderly lung cancer - cohort study of surgery for elderly lung cancer
Chest Surgery, St. Marianna University School of Medicine0 sites1,019 target enrollmentMarch 9, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Chest Surgery, St. Marianna University School of Medicine
- Enrollment
- 1019
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multicenter, retrospective study to assess the safety and efficacy of combination therapy with combination ophthalmic solutions for glaucoma in patients with primary open-angle glaucoma or ocular hypertensioprimary open-angle glaucoma ocular hypertensionJPRN-UMIN000046707Yotsuya Shirato Eye Clinic45
Completed
Not Applicable
Prospective, multicenter study to evaluate the Safety and performance of a syntHetic tissue sealant in reducing fluid lEakage following elective hepatobiLiary anD pancreatic SurgeryFluid leakage following elective hepatobiliary and pancreatic surgery / leakage of bile and pancreatic juices after surgery10019818NL-OMON55236Polyganics BV, Groningen12
Completed
Not Applicable
A multi-center, open-label study to assess the safety and efficacy of combination ceritinib (LDK378) and nivolumab in adult patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (CLDK378A2120C)non small cell lung cancerlung cancer10029107NL-OMON44906ovartis3
Active, not recruiting
Phase 1
A study to test the safety and effects of IMG-7289 in patients with myelofibrosis.Patients with myelofibrosis including primary myelofibrosis (PMF), post-polycythaemia vera myelofibrosis (PPV-MF), and post-essential thrombocythaemia myelofibrosis (PET-MF) (collectively referred to as ‘MF’)MedDRA version: 21.0Level: LLTClassification code 10074692Term: Post essential thrombocythaemia myelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10074691Term: Post polycythaemia vera myelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10077161Term: Primary myelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-003811-23-GBImago BioSciences Inc.75
Active, not recruiting
Phase 1
A study to test the safety and effects of IMG-7289 in patients with myelofibrosisEUCTR2018-003811-23-DEImago BioSciences, Inc.90